Patent ID: 7078384

Claim:
A compound of the formula: R—X 1 —X a —X b —X 2 —NH 2 wherein X 1 is selected from the group consisting of Asn, Asp, Gly, Ser, and Ala; X 2 is selected from the group consisting of Leu and Ile; R is selected from the group consisting of: (a) Cb-(CH 2 ) n —C(O)—X 3 ′— wherein (i) Cb is a carborane, (ii) n is 1, 2, or 3, and (iii) X 3 ′ is selected from the group consisting of a bond, Tyr, Phe, and carboranyl alanine, said carboranyl alanine having the structure: (b) R 1 -L m -X 4 —R 2 —X 3 — wherein (i) X 4 is selected from the group consisting of a bond and Arg, (ii) R 1 is a hydrophobic moiety selected from the group consisting of aromatic containing amine groups, aromatic containing acyl groups, and aliphatic fatty acyl groups, said hydrophobic moiety being effective to render said compound amphiphilic, (ii) m is 0 or 1, (iii) L is a spacer which, when R 1 is an aromatic containing acyl group or an aliphatic fatty acyl group, said spacer is selected from the group consisting of non-polar hydrocarbon groups having an amino group and an acyl group, and uncharged α-amino acids, or when R 1 is an aromatic containing amine group, said spacer is a diacyl group, (iv) R 2 is selected from the group consisting of a bond, an amino acid, and a polypeptide group, said polypeptide group comprising all or a portion of an allatostatin neuropeptide which is naturally contiguous to the C terminal pentapeptide Xaa 3 –Xaa 1 -Phe-Gly-Xaa 2 -NH 2 , wherein said Xaa 1 is selected from the group consisting of Asn, Asp, Gly, Ser, and Ala; Xaa 2 is selected from the group consisting of Leu and Ile, and said Xaa 3 is selected from the group consisting of Tyr and Phe, and which said polypeptide group is less than or equal to about 20 amino acids, and (v) X 3 is selected from the group consisting of Tyr, Phe, and carboranyl alanine; and (c) R 3 -carboranyl alanine-, wherein R 3 is selected from the group consisting of H and Arg; and X a –X b is selected from the group consisting of: (a) -Phe-Caa- wherein Caa is a cycloalkyl alanine group selected from the group consisting of cylcopropyl alanine having the structure: or cyclobutyl alanine having the structure: (b) -Aic-Gly- wherein Aic is a 2-amino-indane-2-carboxyl group having the structure: (c) -Bzd- wherein Bzd is a 1,4-benzodiazepine group having the structure: and (d) -Aic-Caa-.